Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating pulmonary tuberculosis and preparation method thereof

A composition and technology for pulmonary tuberculosis, which can be used in drug combinations, pharmaceutical formulations, and medical preparations containing active ingredients, etc., can solve problems such as side effects of the digestive tract, affecting the recovery of patients, and poor treatment compliance.

Inactive Publication Date: 2017-05-31
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] During the treatment of pulmonary tuberculosis, the clinical tendency is to widely use anti-tuberculosis drugs, but it is easy to ignore the state of patients with low immunity and poor physical fitness to improve the body's physical fitness and resistance, as well as the harmful side effects of tuberculosis drugs on patients, resulting in decreased immunity of patients. And some gastrointestinal side effects occur, and the long-term medication cannot be adhered to, and the treatment compliance is poor, which seriously affects the recovery of patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Embodiment 1: the pharmaceutical composition for the treatment of pulmonary tuberculosis and preparation method thereof

[0036] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating pulmonary tuberculosis are: 126g of Daijindao, 121g of Fujimoto Yeguanmen, 14g of morroniside, 114g of Caoyumei, and 114g of cucurbitacin L7g;

[0037] Preparation:

[0038] (1) Take Dajindao, Fujimoto Yeguanmen, Morroniside, Caoyumei, and Cucurbitacin L according to the ratio of raw materials, mix them evenly, use ethanol with a concentration of 39% by weight as a solvent, and warm-immerse and extract at 36°C to extract The number of times is 14 times, each extraction time is 43 hours, and each solvent consumption is 67 times of the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to a relative density of 1.04, and filters After that, the medicinal sol...

Embodiment 2

[0041] Embodiment 2: the pharmaceutical composition for the treatment of pulmonary tuberculosis and preparation method thereof

[0042] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating pulmonary tuberculosis are: 124g of Dajindao, 122g of Fujimoto Yeguanmen, 122g of morroniside, 118g of Caoyumei, and 118g of cucurbitacin L6g;

[0043] Preparation:

[0044] (1) Take Dajindao, Fujimoto Yeguanmen, Morroniside, Caoyumei, and Cucurbitacin L according to the ratio of raw materials, mix them evenly, use ethanol with a concentration of 39% by weight as a solvent, and warm-immerse and extract at 36°C to extract The number of times is 14 times, each extraction time is 43 hours, and each solvent consumption is 67 times of the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to a relative density of 1.04, and filters After that, the medicinal sol...

Embodiment 3

[0047] Embodiment 3: the pharmaceutical composition for the treatment of pulmonary tuberculosis and preparation method thereof

[0048] The composition and parts by weight of the crude drug of the pharmaceutical composition for treating pulmonary tuberculosis are: 128g of Daijindao, 120g of Fujimoto Yeguanmen, 16g of morroniside, 110g of Caoyumei, and 110g of cucurbitacin L8g;

[0049] Preparation:

[0050] (1) Take Dajindao, Fujimoto Yeguanmen, Morroniside, Caoyumei, and Cucurbitacin L according to the ratio of raw materials, mix them evenly, use ethanol with a concentration of 39% by weight as a solvent, and warm-immerse and extract at 36°C to extract The number of times is 14 times, each extraction time is 43 hours, and each solvent consumption is 67 times of the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to a relative density of 1.04, and filters After that, the medicinal solution p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating pulmonary tuberculosis and a preparation method thereof. The medicine composition is proportionally prepared by using ovate neolepisorus herbs, argyreia osyrensis leaves or roots, morroniside and rhizome and leaves of anemone rivularis and cucurbitacin L as active pharmaceutical ingredients. The medicine composition can be prepared into various dosage forms according to a conventional preparation process; the curative effect on treating pulmonary tuberculosis is obvious.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a medicinal composition for treating pulmonary tuberculosis and a preparation method thereof. Background technique [0002] Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis, which seriously threatens the health and quality of life of patients. In recent years, with the rapid population growth and the mutation of drug-resistant strains, the incidence and recurrence rate of tuberculosis have been on the rise. At present, X-ray manifestations are still the main basis for the diagnosis of pulmonary tuberculosis. Therefore, it is the most effective measure to control pulmonary tuberculosis to clarify the characteristics of pulmonary tuberculosis X-ray manifestations and further improve the correct rate of early diagnosis of pulmonary tuberculosis. With the wide application of clinical anti-tuberculosis drugs, multidrug-resistant ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/71A61P11/00A61P31/06A61K31/7048A61K31/575
CPCA61K36/71A61K31/575A61K31/7048A61K36/12A61K36/39A61K2236/333A61K2236/39A61K2236/55
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com